4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-044584
Chief Tech. Operations Officer sold 10,000 shares at an average $35.78 ($357,787)
- Chief Tech. Operations Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Newell Joe Chief Tech. Operations Officer | 2018-07-30 | Option exercise | +10,000 | $20.40 | $204,000 | 41,858 | D |
| Newell Joe Chief Tech. Operations Officer | 2018-07-30 | Sale | −8,100 | $35.64 | $288,684 | 33,758 | D |
| Newell Joe Chief Tech. Operations Officer | 2018-07-30 | Sale | −1,900 | $36.37 | $69,103 | 31,858 | D |
| Derivatives | |||||||
| Newell Joe Chief Tech. Operations Officer | 2018-07-30 | Option exercise · Employee Stock Option (Right to Buy) | −10,000 | 80,000 | D | ||
| Open-market sales · 10,000 sh · avg $35.78 · $357,787 | |||||||
Loading xslF345X03/doc4.xml…